Institutional Exchange of Cadaver Kidneys in Denmark

Total Page:16

File Type:pdf, Size:1020Kb

Institutional Exchange of Cadaver Kidneys in Denmark Medical History, 2008, 52: 23–46 To Share or not to Share? Institutional Exchange of Cadaver Kidneys in Denmark SØREN BAK-JENSEN* Kidney transplantations are about exchanges. Grafts are moved from dead bodies to living ones in return for gratitude and meaning; between friends and family members out of, or in hope of, affection; and between strangers for philanthropic or pecuniary reasons.1 These exchanges raise legal, psychological, ethical, and philosophical questions, and kidney transplantations owe their high visibility as much to the ongoing debates about these issues as to their therapeutic qualities. Consequently, exchanges like these have received much attention from scholars, stressing how kidney transplantations, along with other kinds of organ transplantations, involve society in a unique way. Rene´e Fox and Judith Swazey, pioneers in the sociological study of kidney transplantations, asserted in 1978 that the importance of renal replacement therapies ‘‘lies as much in their social and cultural significance as in their medical and surgical value’’, thus announcing a broad perspective on the significance of kidney transplantations that continues to dominate non- medical research in the field to this day.2 But kidney transplantations also involve exchanges on a different level. Jeffrey Prottas reminds us that ‘‘before they go to patients, organs go to transplant teams and hospitals’’.3 Doctors and transplant centres involved at this level hold strong vested interests in how organs are distributed, and exchanges at the institutional level are thus potentially as problematic as exchanges on a broader societal level. Prottas identifies two different ways of allocating organs for transplantation. In the first case, organs are distributed according to general criteria accepted by a group of transplant centres and are offered to the most suitable recipient within the network of cooperating centres. In such a system, clinicians in local hospitals have little formal influence on the allocation of grafts, and authority lies primarily with regional or national organ allocation agencies. In the second # Søren Bak-Jensen 2008 exchange. See also Nancy Scheper-Hughes, ‘The global traffic in human organs’, Curr. Anthropol., * Søren Bak-Jensen, PhD, Medical Museion, 2000, 41: 191–224; Margaret Lock, Twice dead: University of Copenhagen, Fredericagade 18, organ transplants and the reinvention of death, DK-1310 Copenhagen K, Denmark; Berkeley, University of California Press, 2002, e-mail: [email protected] pp. 315–40; Anne Hambro Alnæs, Minding matter: The author would like to thank Hanne Jessen, Sniff organ donation and medical modernity’s difficult Andersen Nexø, Susanne Bauer, Jan-Eric Olse´n, decisions, Oslo, Department and Museum of Adam Bencard and Thomas So¨derqvist for Anthropology, Faculty of Social Sciences, commenting on earlier drafts of this article. University of Oslo, 2001. 2 Fox and Swazey, op. cit., note 1 above, p. 376; 1 On different kinds of donor-recipient exchanges, idem, Spare parts: organ replacement in American see Rene´e C Fox and Judith P Swazey, The courage to society, New York, Oxford University Press, 1992. fail: a social view of organ transplants and dialysis, 3 Jeffrey M Prottas, ‘The politics of University of Chicago Press, 1978, pp. 5–39. Fox and transplantation’, in B Spielman (ed.), Organ and tissue Swazey stress the reciprocity involved in organ donation: ethical, legal, and policy issues, donation even when the graft is presented as a gift, Carbondale, Southern Illinois University Press, 1996, and draw on the work by Marcell Mauss on gift pp. 3–18, on p. 5. 23 Downloaded from https://www.cambridge.org/core. IP address: 170.106.35.93, on 02 Oct 2021 at 21:27:06, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0025727300002040 Søren Bak-Jensen case, organs are distributed according to criteria set up by individual transplant centres. Such a system does not preclude the sharing of organs between different hospitals, but, since decisions about allocation are primarily made by local clinicians, there will be a tendency to offer grafts to local patients.4 Just as public and political feelings about the exchange of organs vary a great deal culturally and historically, medical attitudes towards kidney allocation at an institutional level have shifted over time, and both ways of allocat- ing organs can be identified in the history of kidney transplantation. In this article, I shall look at the history of institutional kidney allocation in Denmark, and more precisely at the background of some important changes that took place in the 1980s.5 The first kidney transplantation in Denmark was carried out in 1964.6 In 1969, Danish doctors were central in the establishment of Scandiatransplant, a kidney allocation orga- nization serving the Nordic countries. Transplant centres committed themselves to offering the kidneys they might procure to the most suitable recipient in the region, with tissue type match being the most important allocation criterion. With four transplant centres and the world’s highest transplantation rate for most of the 1970s, Denmark was the main receiver of kidneys in Scandiatransplant, and Danish transplant centres relied heavily on the cooperation with other Nordic centres.7 In 1971, almost 75 per cent of all donor kidneys in this region were exchanged from one hospital to another through Scandiatransplant, and the exchange rate fluctuated around 50 per cent for the next decade. In the early 1980s, this kind of cooperation and the reliance upon histocompatibility came under pressure as more organs were used in the centre where they were procured. Only 15 per cent of all kidneys were exchanged between transplant centres in 1985, and that has remained the average.8 Scandiatransplant performed a series of revisions of exchange criteria, all pointing towards a decrease in regional kidney exchange. Kidney transplantation in Denmark thus went from being regional to being predominantly local in scope. The Danish case has many similarities with developments in other countries in western Europe, which also generally went through a shift from a regional to a local, or from an inter-institutional to an intra-institutional, outlook in kidney exchange.9 During the 1970s, most European transplant centres participated in regional kidney exchange organizations 4 Prottas, op. cit., note 3 above. European countries, see Michael A Bos, The diffusion 5 Since kidneys from living donors are only rarely of heart and liver transplantation across Europe, exchanged between transplant centres, my focus in the London, King’s Fund Centre, 1991. rest of this article is exclusively on the allocation of 7 Jørn Hess Thaysen, Dialyse og kidneys from deceased donors. Systematic nyretransplantation. Organisation af behandling. institutional exchange of kidneys from living donors Indberetning nr. 3 fra sundhedsstyrelsens dialyse og has been suggested, see, for example, Ejvind Kemp, nyretransplantationsudvalg, Copenhagen, Jørn Giese, and Paul Peter Leyssac, Clinical Sundhedsstyrelsen, 1980, p. 30. transplantation, xenotransplantation and stem cell 8 Melvin Madsen, et al., ‘Application of human medicine, Copenhagen, Munksgaard, 2003, leukocyte antigen matching in the allocation of pp. 18–20; E S Woodle, ‘A history of living donor kidneys from cadaveric organ donors in the Nordic transplantation: from twins to trades’, Transplant. countries’, Transplantation, 2004, 77: 621–3; Melvin Proc., 2003, 35: 901–2. Madsen, ‘Scandiatransplant: Nordic collaboration in 6 The history of kidney transplantations in organ transplantation’, in S A Birkeland (ed.), Denmark is presented in Eva Bundegaard, Danske Transplantation in Denmark, Odense, The Danish nyretransplantationer: om pionerer og idealister, Society for Transplantation, 1997, pp. 76–83. Copenhagen, Dansk Nefrologisk Selskab, 1999. For a 9 In contrast, transplant centres in the USA went comparative overview of developments in different through somewhat opposite development during those 24 Downloaded from https://www.cambridge.org/core. IP address: 170.106.35.93, on 02 Oct 2021 at 21:27:06, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0025727300002040 Institutional Exchange of Cadaver Kidneys in Denmark such as Eurotransplant, established in 1967, which served as a model for Scandiatransplant and was soon followed by organizations like France-Transplant and UK Transplant.10 In the 1980s exchange criteria were revised and loosened, and the kidney exchange organiza- tions came to occupy a more marginal role in the allocation of organs.11 The history of institutional kidney allocation in Denmark might thus serve as a case study for develop- ments in Europe more generally. Such a comparative perspective is beyond the scope of this article, but I will continually point out how the Danish case relates to more general developments, both in order to encourage a comparative study of historical practices of organ allocation in different countries, and because events in Denmark were closely connected to and influenced by international discussions. The Danish history may also, however, display particularities that cannot be found elsewhere. Geographically, Denmark is a small country with a well-developed infrastruc- ture, and thus suited for nationwide transportation of organs. Politically, the provision of health care services on the basis of equal
Recommended publications
  • Pediatric Liver Transplantation- a Pediatric Surgery Beacon of Hope Simi Mohan1* 1Department of Pediatrics, Dr
    SMGr up Clinical Article SM Journal of Pediatric Liver Transplantation- A Pediatric Surgery Beacon of Hope Simi Mohan1* 1Department of Pediatrics, Dr. Somervell Memorial CSI Medical College, India Article Information Introduction Received date: Apr 04, 2016 Liver transplantation is an accepted therapy for end stage disease and fulminant hepatic failure. One-year survival has progressively increased to nearly 90% in patients transplanted for most forms Accepted date: Jul 19, 2016 of liver disease. Parallel advances in organ procurement, operative technique, use of safe and potent Published date: Jul 22, 2016 immunosuppressive drugs, and infection control are responsible for improved patient survival. *Corresponding author The history of pediatric liver transplantation has clearly shown that success is dependent on strict and integrated multidisciplinary collaboration [1] among pediatricians, pediatric transplant Simi Mohan, Department of hepatologists, transplant surgeons, nurses, transplant coordinators, psychologists and social Pediatrics, Dr. Somervell Memorial workers. CSI Medical College, India, Email: Liver transplantation was first attempted in dogs by Welch in Albany in 1955 and Cannon [email protected] in California in 1956. The first ever human liver transplantation in the world was performed on Distributed under Creative Commons March1st, 1963 by Thomas E Starzl in Denver, University of Colorado Health Sciences Center CC-BY 4.0 (UCHSC). The recipient was a 3 year old child with Biliary Atresia (Donor - Child who died from brain tumor).The child, however, succumbed to death due to uncontrolled hemorrhage [4]. The first long term survival was achieved in 1967 by Starzl in Denver, Colorado, USA. In July 1967, a two and a half year old child underwent orthotopic liver transplantation.
    [Show full text]
  • Ιστορία Των Μεταμοσχεύσεων Histoire Des Transplantations
    Εργαστήριο Ιστορίας της Ιατρικής Πανεπιστημίου Αθηνών 7η Πανελλήνια Ημερίδα Ιστορίας της Ιατρικής Ιστορία των Μεταμοσχεύσεων Histoire des Transplantations Ο Γάλλος Νομπελίστας Alexis Carrel (1873-1944), O Γάλλος πρωτοπόρος των μεταμοσχεύσεων θεμελιωτής των μεταμοσχεύσεων (δεξιά), παγκρέατος Jean -Michel Dubernard (1941- ) μαζί με τον αεροπόρο Charles Lindbergh ΤΕΛΙΚΟ ΠΡΟΓΡΑΜΜΑ ΥΠΟ ΤΗΝ ΑΙΓΙΔΑ: ΤΟΜΟΣ ΠΕΡΙΛΗΨΕΩΝ • του Ιδρύματος Ιατροβιολογικών Ερευνών της Ακαδημίας Αθηνών • του Εθνικού και Καποδιστριακού Πανεπιστημίου Αθηνών 14 Οκτωβρίου 2011 Ίδρυμα Ιατροβιολογικών Ερευνών της Ακαδημίας Αθηνών Σωρανού του Εφεσίου 4, Αθήνα (Παπάγου) Εργαστήριο Ιστορίας της Ιατρικής Πανεπιστημίου Αθηνών 7η Πανελλήνια Ημερίδα Ιστορίας της Ιατρικής Ιστορία των Μεταμοσχεύσεων Histoire des Transplantations Παρασκευή, 14 Oκτωβρίου 2011 Ίδρυμα Ιατροβιολογικών Ερευνών της Ακαδημίας Αθηνών Σωρανού του Εφεσίου 4, Αθήνα (Παπάγου) ΤΕΛΙΚΟ ΠΡΟΓΡΑΜΜΑ ΤΟΜΟΣ ΠΕΡΙΛΗΨΕΩΝ YΠΟ ΤΗΝ ΑΙΓΙΔΑ του Ιδρύματος Ιατροβιολογικών Ερευνών της Ακαδημίας Αθηνών & του Εθνικού και Καποδιστριακού Πανεπιστημίου Αθηνών ΕΠΙΤΡΟΠΕΣ Président d’ Ηonneur : Jean-Michel Dubernard , Professeur d’Urologie et de Transplantation, Université Claude Bernard, Lyon, France Επίτιμοι Πρόεδροι: Γρηγόριος Σκαλκέας, Ακαδημαϊκός, Πρόεδρος Ιδρύματος Ιατροβιολογικών Ερευνών, Ομ. Καθ. Χειρουργικής Αλκιβιάδης Κωστάκης, Ομ. Καθηγητής Χειρουργικής Ιατρικής Σχολής Αθηνών Πρόεδρος: Γεώργιος Ανδρούτσος, Αν. Καθηγητής, Δ/τής του Εργαστηρίου Ιστορίας της Ιατρικής, της Ιατρικής Σχολής Αθηνών Αντιπρόεδροι: Έφη Πουλάκου-Ρεμπελάκου, Επικ. Καθηγήτρια του Εργαστηρίου Ιστορίας της Ιατρικής, της Ιατρικής Σχολής Αθηνών Μαριάννα Καραμάνου, Ιατρός, Συνεργάτης Εργαστηρίου Ιστορίας της Ιατρικής, Πτυχιούχος Ινστιτούτου Ιστορίας της Ιατρικής, του Πανεπιστημίου Claude Bernard , Λυών, Γαλλίας Τιμητική Επιτροπή Ν. Αγνάντη , τ. Αντιπρύτανης Παν/ου Ιωαννίνων, Ομ. Καθ. Παθολογοανατομίας Π. Γκούμας , τ. Αντιπρύτανης Παν/ου Πατρών, Καθ. ΩΡΛ Θ. Δημητρίου , αν. Πρόεδρος Ιατρικής Σχολής Αλεξ/πολης, Καθ. Ανατομίας Α.-Μ. Δημόπουλος , Πρόεδρος Ιατρικής Σχολής ΕΚΠΑ, Καθ.
    [Show full text]
  • CURRICULUM VITAE Israel Penn, MD Born
    CURRICULUM VITAE Israel Penn, M.D. Born: Rokiskis, Lithuania – January 15, 1930 Citizenship: American Wife’s Name: Zelda Ruth Lebowitz Married – December 29, 1964 Children: Michelle Barbara Jonathan Lawrence Education: Athlone High School, Johannesburg, South Africa Graduated – December, 1946 University of Witwatersrand Medical School Johannesburg, South Africa Graduated – M.B., B.Ch., December, 1952 Royal College of Surgeons of England 1955 – 1956 Certifications: Fellow of Royal College of Surgeons of England, May 1956 Fellow of Royal College of Surgeons of Canada, December 1965 Diplomate of the American Board of Surgery, May 1968, #15575 Other Qualifications: Educational Council for Foreign Medical Graduates, October 1961 Licentiate of the Medical Council of Canada, November 1964 Licensure: Colorado 1969 South African Medical Council 1952 General Medical Council of Great Britain 1955 Manitoba, Canada 1965 Ohio 7/23/82 Israel Penn, M.D. 2 EXPERIENCE: Housesurgeon (Intern) to Mr. A. Lee McGregor Jan. – July, 1953 (Senior Surgeon), Johannesburg General Hospital & University of Witwatersrand Medical School (General Surgery). Housephysician (Intern) to Mr. M.M. Suzman (Senior Aug. 1953 – Jan. 1954 Physician), at the above hospital (Internal Medicine). Orthopedic Housesurgeon (equivalent to “Resident” Feb. 1954 – July 1954 status) to Mr. J.M. Edelstein (Senior Orthopedic Surgeon), at the above hospital (Orthopedic Surgery). Casualty Officer (equivalent to “Resident” status) Transvaal Aug. 1954 – Jan. 1955 Memorial Hospital for Children and University of Witwatersrand Medical School (Pediatric Surgery). Senior Housesurgeon (equivalent to “Resident” status) July 1955 – Jan. 1956 to Mr. W.G. MacLean (Senior Surgeon) Swansea General Hospital, Swansea, Great Britain (General Surgery and Urology). Senior Housesurgeon (equivalent to “Resident” status) June 1956 – Nov.
    [Show full text]
  • Announcement from the General
    ANNOUNCEMENT FROM THE GENERAL SECRETARIAT OF THE KING FAISAL INTERNATIONAL PRIZE ON THE RESULTS OF THE SELECTION COMMITTEES IN THEIR MEETINGS HELD BETWEEN 13/9/1421H-16/9/1421H CORRESPONDING TO 9/12/2000G-12/2/2000G Riyadh, 12 December 2000. At an official dinner held at Riyadh's AI Khozama Centre, HRH Prince Khaled AI Faisal, Director-General of King Faisal Foundation, announced the winners of the prestigious King Faisal International Prize for 2001. Professor Sir Roy Yorke Calne (Emeritus Professor of Surgery, University of Cambridge, UK), Professor Norman Edward Shumway (Professor and Chairman of the Department of Cardiothoracic Surgery, Stanford University, California, USA), and Professor Thomas Earl Starzl (Professor of Surgery, University of Pittsburg, Pennsylvania, USA) have jointly been awarded the King Faisal International Prize for Medicine for their outstanding contributions in the field of organ transplantation. Professor Calne's pioneering experimental and clinical research on the use of immunosuppressive drugs and other aspects of transplantation has led to the introduction into clinical practice of 6-mercaptopurine (1960), azathioprine (1961) and, most importantly, cyclosporin (1970). Professor Caine's research on these drugs paved the way for heart, lung, liver, pancreas and kidney transplantation to become standard procedures throughout the world, thereby benefiting huge numbers of patients. Professor Caine also pioneered the use of monoclonal antibodies to prevent graft rejection and made the seminal discovery that liver transplantation is of itself immunosuppressive. This has led to the concept that it may be possible to reduce the use of immunosuppressive drugs in recipients of liver and other organ transplants. Professor Shumway is considered to be the father of heart transplantation.
    [Show full text]
  • 2020 Virtual CONVOCATION CEREMONY
    AMERICAN COLLEGE OF SURGEONS 2020 Virtual CONVOCATION CEREMONY SUNDAY, OCTOBER 4, 2020 Congratulations TO ALL OF THE INITIATES OF 2020. Although we can't congratulate you in person, we want to make sure this time is as special for you as past ceremonies. 2 CONTENTS 3 ABOUT THE COLLEGE O The American College of Surgeons (ACS) is the largest organization of surgeons in the world, uniquely positioned to lead the way in optimal patient care, surgical research, health policy, and continuing education and networking opportunities. It is the single strongest voice for surgeons in all specialties and, since its founding in 1913 by surgeons from the United States and Canada, has been at the forefront of providing quality care for surgical patients and supporting surgeons wherever they practice. The College works on behalf of our members and their patients by: Developing innovative educational and training programs to support practicing surgeons, surgery residents, medical students, and surgical team members Improving care for surgical patients through American College of Surgeons Quality Programs, including the Cancer Programs, the Committee on Trauma (COT), and the ACS National Surgical Quality Improvement Program (ACS NSQIP®) Fostering the next generation of promising surgeons through scholarships and fellowships Conducting research to provide cutting-edge best practices in patient care Giving surgeons from across the U.S. and around the globe opportunities for networking Promoting the image of the surgical profession, today and tomorrow The FACS Designation The FACS designation (Fellow, American College of Surgeons) after a surgeon’s name means that the surgeon’s education and training, professional qualifications, surgical competence, and ethical conduct have undergone a rigorous evaluation and have been found to be consistent with the high standards established and demanded by the College.
    [Show full text]
  • Liver Transplantation
    Liver Transplantation Liver Transplantation Author Dilip Chakravarty K Division of HPB Surgery and Liver Transplantation Department of General Surgery Chang Gung Memorial Hospital (Linkou) Taipei, Taiwan (ROC) Co-authors WC Lee YY Jan Professor and Chief Professor and Chairman Department of Liver and Transplantation Surgery Department of General Surgery Chang Gung Transplantation Institute (Linkou) Chang Gung Memorial Hospital (Linkou) Chang Gung University Chang Gung University Taipei, Taiwan (ROC) Taipei, Taiwan (ROC) Po-Huang Lee YC Chen Professor of Surgery and Chairman Department of Nephrology Department of Surgery and Chang Gung Memorial Hospital (Linkou) Liver Transplantation Program Chang Gung University National Taiwan University Hospital Taipei, Taiwan (ROC) Taipei, Taiwan (ROC) Foreword Sir Roy Calne ® JAYPEE BROTHERS MEDICAL PUBLISHERS (P) LTD St Louis (USA) • Panama City (Panama) • New Delhi • Ahmedabad • Bengaluru • Chennai Hyderabad • Kochi • Kolkata • Lucknow • Mumbai • Nagpur Published by Jitendar P Vij Jaypee Brothers Medical Publishers (P) Ltd Corporate Office 4838/24 Ansari Road, Daryaganj, New Delhi 110 002, India Phone: +91-11-43574357, Fax: +91-11-43574314 Registered Office B-3 EMCA House, 23/23B Ansari Road, Daryaganj, New Delhi 110 002, India Phones: +91-11-23272143, +91-11-23272703, +91-11-23282021, +91-11-23245672, Rel: +91-11-32558559 Fax: +91-11-23276490, +91-11-23245683 e-mail: [email protected], Website: www.jaypeebrothers.com Branches 2/B, Akruti Society, Jodhpur Gam Road Satellite, Ahmedabad 380
    [Show full text]
  • Press Release Winners Announced 2001/1421H the King Faisal Nternational Prize for Medicine
    PRESS RELEASE WINNERS ANNOUNCED 2001/1421H THE KING FAISAL NTERNATIONAL PRIZE FOR MEDICINE Topic: ORGAN TRANSPLANTATION The King Faisal International Prize in Medicine has been awarded to: Professor Sir Roy Yorke Calne Emeritus Professor of Surgery, University of Cambridge, UK Professor Norman Edward Shumway Professor and Chairman of Department of Cardiothoracic Surgery, University of Stanford, California, USA Professor Thomas Earl Starzl Professor of Surgery, University of Pittsburg, Pennsylvania, USA Professor Sir Roy Calne FRCS, FRS, Emeritus Professor of Surgery at the University of Cambridge, was born in the UK in 1930 and received his medical training at Guy's Hospital, London. Professor Calne later spent two years as a Research Fellow in Surgery at Harvard Medical School. Upon his return to UK he held surgical posts at St. Mary's and West minister Hospitals before he became Professor of Surgery at the University of Cambridge, a post which he held until he retired in 1998. Professor Calne is being honored for his pioneering experimental and clinical research on the use of immunosuppressive drugs and other aspects of transplantation, documented in more than 500 scientific papers. His work led to the introduction into clinical practice of 6- mercaptopurine (1960), azathioprine (1961) and, most importantly, cyclosporine (1970). Professor Calne's research on these drugs paved the way for heart, lung, liver, pancreas and kidney transplantation to become standard procedures throughout the world, thereby benefitting huge numbers of patients. Professor Caine also pioneered the use of monoclonal antibodies to prevent graft rejection, and made the seminal discovery that liver transplantation is of itself immunosuppressive.
    [Show full text]
  • THANKS to OUR REFEREES It Is Once More a Pleasure to Acknowledge the Enormous Help Given by Referees up to 30June 1989
    THANKS TO OUR REFEREES It is once more a pleasure to acknowledge the enormous help given by referees up to 30June 1989. In an effort to improve the standard of published papers we have placed an increasing burden on the reviewers. Our success is reflected in the enormous increase in proffered articles and we accept only about 30% of those we see. Thank you for your help. Please continue to act as referees. R M KIRK, Editor Anthony Adams Jean-Claude Gazet Michael Owen-Smith John Alexander-Williams Alan Gilston Roger Parker Patricia Allen Frederick Given Simon Paterson-Brown Tim Allen-Mersh Malcolm Gough John Payne Alan Apley John Groves John Pepper Douglas Arthur Robert Gumpert Richard Plummer Brian Sterry Ashby David Hamer Alan Pollock Michael Handley Ashken George Hamilton Roy Pounder Mike Baddeley Jack Hardcastle Grant Radcliffe Peter Baird Arthur Hargreaves David Ralphs Roger Baird Don Harrison Andrew Ransford Michael Baum David Hatch John Rennie John Beaugie David Hay John Rickett Peter Bell Peter Heath Paul Rogers Eddie Benson Brian Heather Tony Rubin George Bentley Tom Hennessy Geoffrey Rushman Donald Bethune Penelope Hewitt Chris Russell Roger Blamey Edmund Hoare Roger Sage John Blandy Michael Horrocks GeoffSagor John Bolton Michael Hubbard Richard Sainsbury John Bradbeer David Hunt John Sale Tom Brennan Clem Imrie John Samuel Philip Britton Miles Irving Ivor Schraibman Ivor Broomhead Georges Jantet Frank Schweitzer Ashley Brown PatrickJeffery John Scurr Colin Brown Alan Johnson Jonathan Secker-Walker Norman Browse BarryJones William
    [Show full text]
  • Major Medical Milestones Leading up to the First Human Heart Transplantation
    University of Calgary PRISM: University of Calgary's Digital Repository Conferences History of Medicine Days 2009 Major Medical Milestones Leading Up to the First Human Heart Transplantation Elzinga, Kate Cambridge Scholars Publishing Elzinga, K. "Major Medical Milestones Leading Up to the First Human Heart Transplantation". The Proceedings of the 18th Annual History of Medicine Days, March 6th and 7th, 2009 University of Calgary, Faculty of Medicine, Calgary, AB. p. 177-200 http://hdl.handle.net/1880/48963 journal article Downloaded from PRISM: https://prism.ucalgary.ca MAJOR MEDICAL MILESTONES LEADING UP TO THE FIRST HUMAN HEART TRANSPLANTATION KATE ELZINGA SUMMARY: Throughout the historiography of cardiac surgery, it was claimed that the first heart operation was performed in 1801 by Catalonian physician Francisco Romero (ca. 1770-1815?). His pericardiostomy involved making a thoracic incision, then opening and draining the pericardium. “Blood oxygenation” did not restrict this type of minor surgery, but proved to be a significant barrier limiting cardiac surgery for the next 150 years. Open heart surgery only became possible with the creation of the cardiopulmonary bypass machine and the use of medically induced hypothermia. Dr. Wilfred Bigelow (1913-2005) discovered that if dogs were cooled to 25-30°C, they could be brought back to consciousness in warm water, which was very encouraging because heart operations would be safer if a patient’s oxygen demands were decreased during surgery. This article will address some not-so-well known Canadian achievements leading up to the development of cardiac surgery in general and heart transplantation in particular and put them into their perspective in the wider history of medicine.
    [Show full text]
  • Die Protektive Wirkung Von Quercetin-3-Glucuronid Bei Xenogener Herztransplantation Im Ex Vivo Perfusionsmodell
    Aus der Klinik fur¨ Anasthesiologie¨ der Ludwig-Maximilians-Universitat¨ Munchen¨ Direktor: Herr Prof. Dr. med. Bernhard Zwißler Die protektive Wirkung von Quercetin-3-glucuronid bei xenogener Herztransplantation im ex vivo Perfusionsmodell Dissertation zum Erwerb des Doktorgrades der Medizin an der Medizinischen Fakultat¨ der Ludwig-Maximilians-Universitat¨ zu Munchen¨ vorgelegt von Regina Elisabeth Ebert aus Fulda 2015 Mit Genehmigung der Medizinischen Fakultat¨ der Universitat¨ Munchen¨ Berichterstatter: Herr Priv.-Doz. Dr. med. Andreas Bauer Mitberichterstatter: Herr Prof. Dr. med. Michael Schmoeckel Herr Priv.-Doz. Dr. med. Stephan Lederer Dekan: Herr Prof. Dr. med. Dr. h. c. M. Reiser, FACR, FRCR Tag der mundlichen¨ Prufung:¨ 18.06.2015 2 Inhaltsverzeichnis Abkurzungsverzeichnis¨ 6 Abbildungsverzeichnis 8 Tabellenverzeichnis 10 1 Einleitung 11 1.1 Relevanz der Xenotransplantation fur¨ die Herztransplantationsmedizin . 11 1.1.1 Problematik des Organspendemangels . 11 1.1.2 Definition und Entwicklung der Xenotransplantation . 13 1.1.3 Das Schwein als Spender fur¨ die Xenotransplantation . 14 1.2 Hyperakute Abstoßungsreaktion . 15 1.3 Ischamie-/Reperfusionsschaden¨ . 18 1.4 Working-Heart-Modell . 19 1.5 Flavonoide . 20 1.5.1 Wirkungsmechanismen von Flavonoiden . 22 1.5.2 Spezifische Wirkungsmechanismen von Quercetin-3-glucuronid . 24 1.6 Fragestellung der vorliegenden Arbeit . 27 2 Material und Methoden 28 2.1 Versuchsgruppen . 28 2.2 Operatives Vorgehen . 28 2.2.1 Anasthesie¨ . 28 2.2.2 Operation . 29 2.2.3 Herzpraparation¨ . 31 3 2.3 Working-Heart-Modell . 32 2.3.1 Aufbau . 34 2.3.2 Perfusat . 35 2.4 Versuchsablauf . 37 2.5 Messparameter . 38 2.5.1 Funktionsparameter . 38 2.5.1.1 Hamodynamik¨ .
    [Show full text]
  • ORGAN TRANSPLANTATION the Ki
    PRESS RELEASE WINNERS ANNOUNCED 2001/1421H THE KING FAISAL NTERNATIONAL PRIZE FOR MEDICINE Topic: ORGAN TRANSPLANTATION The King Faisal International Prize in Medicine has been awarded to: Professor Sir Roy Yorke Calne Emeritus Professor of Surgery, University of Cambridge, UK Professor Norman Edward Shumway Professor and Chairman of Department of Cardiothoracic Surgery, University of Stanford, California, USA Professor Thomas Earl Starzl Professor of Surgery, University of Pittsburg, Pennsylvania, USA Professor Sir Roy Calne FRCS, FRS, Emeritus Professor of Surgery at the University of Cambridge, was born in the UK in 1930 and received his medical training at Guy's Hospital, London. Professor Calne later spent two years as a Research Fellow in Surgery at Harvard Medical School. Upon his return to UK he held surgical posts at St. Mary's and West minister Hospitals before he became Professor of Surgery at the University of Cambridge, a post which he held until he retired in 1998. Professor Calne is being honored for his pioneering experimental and clinical research on the use of immunosuppressive drugs and other aspects of transplantation, documented in more than 500 scientific papers. His work led to the introduction into clinical practice of 6-mercaptopurine (1960), azathioprine (1961) and, most importantly, cyclosporine (1970). Professor Calne's research on these drugs paved the way for heart, lung, liver, pancreas and kidney transplantation to become standard procedures throughout the world, thereby benefitting huge numbers of patients. 1 Professor Caine also pioneered the use of monoclonal antibodies to prevent graft rejection, and made the seminal discovery that liver transplantation is of itself immunosuppressive.
    [Show full text]